ClinicalTrials.gg
RecruitingNCT05798741Updated Oct 23, 2026

Hardware Removal After ORIF of Ankle Fractures

An interventional study of Hardware removal in Ankle Fractures, sponsored by Hôpital Fribourgeois. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Hôpital Fribourgeois · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.
Updated Oct 23, 2026Now RecruitingFirst site in Switzerland+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Ankle fractures account for 10 % of fractures in the adult population. A part of patients (40%) is treated surgically. After healing of the fractures, about one year after the operation, a surgery is often performed to remove the hardware in order to diminish pain. If this surgery is necessary is debated in the literature.

The aim of our study is to evaluate the outcome of hardware removal surgery after a surgery of the ankle for a fracture. For that, we will perform do a controlled randomized trial with two arms: one arm includes the participants who will have a hardware removal and the other arm will not have a surgery.

Outcome parameters are the patients reported outcome and pain related disability. They will be assessed by the questionnaires FAAM score (Foot and Ankle Ability Measure) and PDI (Pain Disability Index) at the beginning and at the end of the study, at six months. The third outcome parameter will be the complication rate after an anklehardware removal surgery, which will be assessed through the Ernst-Ssink classification.

Read the detailed description

The study consists of a prospective multicentric parallel two-arm randomised non-blinded study, conducted at the HFR and RHNe (level of evidence II).

The planned intervention is the following: after an ORIF of the ankle, patients have a follow-up. At the 12- month control, we ask eligible patients if they want to participate to the study. If they agree, they are randomised to treatment recommendations in one of two groups: conservative or surgical. The patients may follow or not the recommendations; not following the recommendations does not exclude them from the study. Patients of both groups will fill out FAAM and PDI questionnaires at 12 and 18 months after the 1st operation. Patients in the surgical group will have a hardware removal surgery. It is a very common operation consisting of hardware removal that is done ambulatory by the orthopaedic surgeons specialized in foot and ankle surgery. Operated patients will have the usual postoperative follow-up (6 weeks, 3 months and 6 months postoperative) and all complications will be recorded and classified according to the Ernst-sink classification

02

Conditions studied

  • Ankle Fractures

Browse trials for

03

In context

Ankle Fractures

203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.

This study's planned enrollment of 100 is above the median of 90 across 151 interventional studies indexed under Ankle Fractures.

Browse Ankle Fractures studies →

Lead sponsor

Hôpital Fribourgeois is the lead sponsor of 18 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >18 y.o
  • Operative treatment of ankle/foot fractures at HFR or RHNe:
  • Ankle fractures: bi-malleolar and tri-malleolar fractures or equivalent
  • FAAM score >5%, \<95%
  • Patient expected to complete length of study
  • Patient with sufficient cognitive and linguistic ability in order to participate in the study.
  • Operable patients ( ≤3)

Exclusion criteria

Exclusion Criteria:

  • Absolute indications for HR: infection/malunion/allergy to metal/refracture
  • Ankle fractures that are not listed in the criteria above
  • Patient treated for a fracture at the same foot/ ankle before
  • Patient with fracture of two different regions of the foot/ankle
  • Patient treated for the fracture outside of HFR and RHNe
  • Patient non ambulating before time of injury
  • Patients having diabete,
  • under chemotherapy,
  • Peripheral artery disease stade IV
  • Pregnant patients
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Hardware removal

    hardware removal

    Procedure: Hardware removal

  • No intervention
    hardware retaining

    Patients that retain their hardware

Interventions

  • ProcedureHardware removal

    The surgery of hardware removal after an ORIF of an ankle fracture

06

What researchers measure

Primary outcomes

  1. patient reported outcome after an ankle hardware removal

    FAAM score (Foot and Ankle Ability Measure). FAAM subdivided in AVQ scale(84 points) and Sport scale (32 points). The higher is a better outcome.

    Time frame: 6 months

Secondary outcomes

  1. pain-related disability after an ankle hardware removal

    PDI (Pain Disability Index). Total of 70 points. The higher means a worse outcome.

    Time frame: 6 months

  2. complication rate after an ankle hardware removal surgery

    Ernst-sink classification

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • HFR
    Fribourg, 1752, Switzerland
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2028, 62 months after the start.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 62 months is above that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start May 2023 → Oct 2023, primary completion Jun 2025 → Dec 2028 and completion Mar 2026 → Dec 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2023
First posted
Apr 5, 2023
StartActual
Oct 1, 2023was May 2023
Primary completionEst.
Dec 31, 2028was Jun 2025
CompletionEst.
Dec 31, 2028was Mar 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 23, 2026
Sites
1 site added — first site in Switzerland
Show site
  • HFR · Fribourg, Switzerland
Oct 23, 2026
Start date
May 1, 2023→Oct 1, 2023 (actual)
Oct 23, 2026
Primary completion
Jun 1, 2025→Dec 31, 2028
Oct 23, 2026
Study completion
Mar 1, 2026→Dec 31, 2028
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Switzerland
    Show site
    • HFR · Fribourg, Switzerland
    Start date May 1, 2023→Oct 1, 2023 (now actual)
    Primary completion Jun 1, 2025→Dec 31, 2028
    Study completion Mar 1, 2026→Dec 31, 2028
    + 3 other changes: identifiers, verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05798741
Lead sponsor
Hôpital Fribourgeois
Responsible party
Sponsor
First posted
Apr 5, 2023
Start date
Oct 1, 2023
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Amal Chidda
Contact
amal.chidda@h-fr.ch
+41788540681

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion